| Next 10 |
Ad
NURO News and Press NeuroMetrix Inc.
News | NeuroMetrix Inc. (NASDAQ:NURO)
-
WOBURN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and nine months ended September 30, 2024. The Company develops proprietary non-invasive medical devices for the diagnosis and treatment of pain and ne...
-
WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today for the purpose of clarity, reiterated that the Company is engaged in a review of strategic alternatives. In February of this year, the Company announced that it had initiated a review of strategic optio...
-
2024-08-10 00:33:09 ET NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Conference Call August 06, 2024, 08:00 AM ET Company Participants Thomas Higgins - Senior Vice President and Chief Financial Officer Shai Gozani - Founder and Chief Executive Officer Conference Ca...
-
2024-08-06 11:54:49 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips NeuroMetrix (NASDAQ: NURO ) just reported results for the second quarter of 2024. NeuroMetrix reported earnings per share of -74 cents. The company reported revenue of...
-
2024-08-06 07:25:05 ET More on NeuroMetrix Financial information for NeuroMetrix Read the full article on Seeking Alpha For further details see: NeuroMetrix GAAP EPS of -$0.74, revenue of $0.8M
-
WOBURN, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and six months ended June 30, 2024. The Company's mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-...
-
WOBURN, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2024 second quarter business and financial highlights before the opening of the market on August 6, 2024. The Company will host a conference call at 8:00 a.m., Eastern Time...
-
2024-05-15 17:26:29 ET More on NeuroMetrix NeuroMetrix, Inc. (NURO) Q4 2023 Earnings Call Transcript Financial information for NeuroMetrix Read the full article on Seeking Alpha For further details see: NeuroMetrix GAAP EPS of -$1.67
-
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2024. The Company's mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-invasive medica...
-
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Stock Information
Get NURO Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
WOBURN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and nine months ended September 30, 2024. The Company develops proprietary non-invasive medical devices for the diagnosis and treatment of pain and ne...
-
WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today for the purpose of clarity, reiterated that the Company is engaged in a review of strategic alternatives. In February of this year, the Company announced that it had initiated a review of strategic optio...